Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
about
Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review)Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomasUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionRelationship between tumor size and disease stage in non-small cell lung cancer.Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesis.The assessment of the role of baseline low-dose CT scan in patients at high risk of lung cancerTwo microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.Biomarkers for risk assessment in molecular epidemiology of cancer.Significance of non-calcified pulmonary nodules in patients with extrapulmonary cancersCould CT screening for lung cancer ever be cost effective in the United Kingdom?Factors influencing hospital costs of lung cancer patients in Northern Ireland.Clinical impact of high-throughput gene expression studies in lung cancer.Curcumin inhibits COPD-like airway inflammation and lung cancer progression in miceMassive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumorsThe tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosisDesign and Development of a New Multi-Projection X-Ray System for Chest Imaging.Glucosidase II beta subunit (GluIIβ) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner.Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q24617128-4A3633FE-E4FE-4E96-8406-13D2F437AAEAQ24669579-8130CFED-3EBC-4866-9A0D-80F0E21F7888Q28388931-01E27246-7F2E-4EEC-8531-55FD56B8018EQ33682854-8977A84B-806F-4E79-ADCD-4C4009B48D28Q33789403-30CB8A6D-3C7B-4702-B225-97B3EA174580Q33933709-31B166A0-6B88-400E-ADD6-AA5FE3B7F3E9Q34435850-0C1B9CD1-1273-414F-8578-E4EC7AD8E66FQ35904013-64B071C6-2393-4A4B-BBAF-A5280DFFBF9BQ36184003-9380E985-592F-49C3-9593-A7C60022514EQ36537744-C2CF3389-00CB-4C11-9226-0674596FD7A5Q36777448-88EBED9A-CE60-4795-8AE5-52BAAAA214A5Q37317171-829FCDAD-1E6C-4F69-A5FE-3AD90F5466F7Q37437260-8D1D96CF-7045-4CCF-92AF-874676F11A73Q37514029-859B2113-3514-4A20-A9F4-453ED77314A8Q41537567-3E4F2FAC-C904-47C4-9FBF-B9D9451034CAQ48502775-01B932D9-A6E2-4C8E-B9B1-41918FFAC656Q52755076-83240BB4-E900-4636-BFF7-6B3F5E84EB29Q59274190-95E6F6CF-E9DE-4611-A7D8-60DEE7F6B958
P2860
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@en
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@nl
type
label
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@en
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@nl
prefLabel
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@en
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@nl
P1433
P1476
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
@en
P2093
David E Midthun
James R Jett
P304
P356
10.1378/CHEST.125.5_SUPPL.158S
P407
P433
P577
2004-05-01T00:00:00Z